Zealand Pharma Feed

Land	Danmark
Lista	Large Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2023-11-30 17:15:00 Total number of shares and voting rights in Zealand Pharma at November 30, 2023 -1,73% | 105 MDKK

2023-11-30 08:00:00 Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers +2,63% | 132 MDKK

2023-11-16 22:00:00 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants -0,79% | 48,0 MDKK

2023-11-09 07:00:00 Zealand Pharma Announces Financial Results for the First Nine Months of 2023 +2,83% | 95,8 MDKK

2023-11-07 10:00:00 Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023 -1,79% | 52,9 MDKK

2023-11-03 17:00:00 Zealand Pharma conference call on November 9 at 2pm CET (8am ET) to present third quarter 2023 results -4,52% | 76,0 MDKK

2023-10-20 22:00:00 Zealand Pharma major shareholder announcement: Polar Capital 0,00% | 70,1 MDKK

2023-10-17 08:00:00 Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek +0,75% | 43,3 MDKK

2023-10-05 11:53:22 Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease +0,06% | 69,1 MDKK

2023-09-29 17:15:00 Total number of shares and voting rights in Zealand Pharma at September 29, 2023 -0,98% | 73,7 MDKK

2023-09-14 22:30:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons -1,45% | 112 MDKK

2023-09-14 22:00:00 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants -1,45% | 112 MDKK

2023-09-08 11:00:00 SAVE THE DATE: Zealand Pharma to host Obesity R&D Event in London on December 5, 2023 +1,04% | 19,7 MDKK

2023-09-07 17:00:00 Zealand Pharma to participate in upcoming healthcare conferences in September 2023 +1,04% | 19,7 MDKK

2023-08-31 17:35:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +0,55% | 32,7 MDKK

2023-08-31 17:30:00 Total number of shares and voting rights in Zealand Pharma at August 31, 2023 +0,55% | 32,7 MDKK

2023-08-30 07:33:26 Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism -1,95% | 30,4 MDKK

2023-08-25 16:45:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +0,15% | 38,4 MDKK

2023-08-24 22:00:00 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants +0,15% | 38,4 MDKK

2023-08-17 07:00:00 Zealand Pharma Announces Financial Results for the First Half of 2023 +4,33% | 49,7 MDKK

2023-08-14 17:05:00 Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results -0,51% | 21,3 MDKK

2023-07-03 12:01:08 Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396 -0,25% | 87,0 MDKK

2023-06-30 19:32:31 Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism -0,25% | 87,0 MDKK

2023-06-30 17:05:00 Total number of shares and voting rights in Zealand Pharma at June 30, 2023 -0,25% | 87,0 MDKK

2023-06-26 08:30:00 Zealand Pharma Submits Marketing Authorization Application for Dasiglucagon for Treatment of Severe Hypoglycemia in Diabetes to the European Medicines Agency -1,78% | 122 MDKK

2023-06-24 17:35:00 Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions -1,78% | 122 MDKK

2023-06-23 23:15:00 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906) -1,78% | 122 MDKK

2023-06-08 22:00:00 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants +2,92% | 69,8 MDKK

2023-06-06 17:00:00 Zealand Pharma to Participate in Upcoming Healthcare Conferences -2,97% | 33,3 MDKK

2023-05-31 17:05:00 Total number of shares and voting rights in Zealand Pharma at May 31, 2023 -0,75% | 30,7 MDKK

2023-05-25 22:00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +0,08% | 63,1 MDKK

2023-05-23 22:00:00 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants -3,28% | 62,2 MDKK

2023-05-12 21:00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +1,09% | 96,8 MDKK

2023-05-11 07:00:00 Zealand Pharma Announces Financial Results for the First Quarter of 2023 +11,64% | 172 MDKK

2023-05-10 08:30:00 Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight -1,87% | 113 MDKK

2023-05-04 17:05:00 Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results +0,27% | 23,4 MDKK

2023-04-28 17:05:00 Total number of shares and voting rights in Zealand Pharma at April 28, 2023 -1,40% | 7,30 MDKK

2023-04-25 19:30:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons -5,71% | 111 MDKK

2023-04-19 22:00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons 0,00% | 33,3 MDKK

2023-04-19 21:45:00 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors, Corporate Management and employees for 2023 0,00% | 33,3 MDKK

2023-04-12 17:00:00 Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference +4,73% | 218 MDKK

2023-04-04 08:32:30 Zealand Pharma completes registration of capital increase +5,35% | 90,0 MDKK

2023-04-03 09:29:02 Zealand Pharma A/S publishes a listing prospectus regarding admission to trading and official listing of 6,578,948 new shares on Nasdaq Copenhagen -4,28% | 165 MDKK

2023-03-31 17:05:00 Total number of shares and voting rights in Zealand Pharma at March 31, 2023 -4,28% | 165 MDKK

2023-03-30 22:45:00 Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion -10,72% | 297 MDKK

2023-03-30 17:01:00 Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares -10,72% | 297 MDKK

2023-03-29 20:00:00 Zealand Pharma's Annual General Meeting 2023 -2,27% | 53,8 MDKK

2023-03-28 22:00:00 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants +6,95% | 84,2 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2023-11-09	Kvartalsrapport 2023-Q3
2023-08-17	Kvartalsrapport 2023-Q2
2023-05-11	Kvartalsrapport 2023-Q1
2023-03-30	Ordinarie utdelning ZEAL 0.00 DKK
2023-03-29	Årsstämma 2023
2023-03-02	Bokslutskommuniké 2022
2022-11-10	Kvartalsrapport 2022-Q3
2022-08-11	Kvartalsrapport 2022-Q2
2022-05-12	Kvartalsrapport 2022-Q1
2022-05-09	Ordinarie utdelning ZEAL 0.00 DKK
2022-04-06	Årsstämma 2022
2022-03-10	Bokslutskommuniké 2021
2021-11-11	Kvartalsrapport 2021-Q3
2021-08-12	Kvartalsrapport 2021-Q2
2021-05-12	Kvartalsrapport 2021-Q1
2021-04-16	Ordinarie utdelning ZEAL 0.00 DKK
2021-04-15	Årsstämma 2021
2021-03-11	Bokslutskommuniké 2020
2020-11-12	Kvartalsrapport 2020-Q3
2020-08-13	Kvartalsrapport 2020-Q2
2020-05-14	Kvartalsrapport 2020-Q1
2020-04-03	Ordinarie utdelning ZEAL 0.00 DKK
2020-04-02	Årsstämma 2020
2020-03-12	Bokslutskommuniké 2019
2019-11-14	Kvartalsrapport 2019-Q3
2019-08-15	Kvartalsrapport 2019-Q2
2019-05-16	Kvartalsrapport 2019-Q1
2019-04-05	Ordinarie utdelning ZEAL 0.00 DKK
2019-04-04	Årsstämma 2019
2019-03-07	Bokslutskommuniké 2018
2018-11-15	Kvartalsrapport 2018-Q3
2018-08-16	Kvartalsrapport 2018-Q2
2018-05-16	Kvartalsrapport 2018-Q1
2018-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2018-04-19	Årsstämma 2018
2018-03-07	Bokslutskommuniké 2017
2017-11-08	Kvartalsrapport 2017-Q3
2017-08-24	Kvartalsrapport 2017-Q2
2017-05-17	Kvartalsrapport 2017-Q1
2017-04-06	Ordinarie utdelning ZEAL 0.00 DKK
2017-04-05	Årsstämma 2017
2017-03-15	Bokslutskommuniké 2016
2016-11-09	Kvartalsrapport 2016-Q3
2016-08-25	Kvartalsrapport 2016-Q2
2016-05-18	Kvartalsrapport 2016-Q1
2016-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2016-04-19	Årsstämma 2016
2016-03-16	Bokslutskommuniké 2015
2015-11-05	Kvartalsrapport 2015-Q3
2015-08-28	Kvartalsrapport 2015-Q2
2015-05-22	Kvartalsrapport 2015-Q1
2015-04-22	Ordinarie utdelning ZEAL 0.00 DKK
2015-04-21	Årsstämma 2015
2015-03-12	Bokslutskommuniké 2014
2014-11-07	Kvartalsrapport 2014-Q3
2014-08-21	Kvartalsrapport 2014-Q2
2014-05-06	Kapitalmarknadsdag 2014
2014-04-29	Årsstämma 2014
2014-04-29	Kvartalsrapport 2014-Q1
2014-03-21	Ordinarie utdelning ZEAL 0.00 DKK
2014-03-20	Bokslutskommuniké 2013
2013-11-15	Kvartalsrapport 2013-Q3
2013-08-29	Kvartalsrapport 2013-Q2
2013-05-15	Kvartalsrapport 2013-Q1
2013-04-30	Årsstämma 2013
2013-04-30	Ordinarie utdelning ZEAL 0.00 DKK
2013-03-14	Bokslutskommuniké 2012
2012-11-29	Kapitalmarknadsdag 2012
2012-04-26	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-25	Årsstämma 2012
2011-11-17	Kvartalsrapport 2011-Q3
2011-10-25	Kapitalmarknadsdag 2011
2011-08-18	Kvartalsrapport 2011-Q2
2011-05-12	Kvartalsrapport 2011-Q1
2011-04-29	Ordinarie utdelning ZEAL 0.00 DKK
2011-04-28	Årsstämma 2011

Zealand Pharma

Kalender

Beskrivning

Zealand Pharma

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden